JAK1-IN-13

JAK1-IN-13 (compound 36b) is a potent and highly selective oral JAK1 inhibitor with a 0.044 nM IC50, effectively suppressing STAT3 phosphorylation. It is a valuable research tool for investigating JAK1-dependent pathways in autoimmune and inflammatory disease models, both in vitro and in vivo.